NCT05797350 is a NA clinical trial of Glaucoma Drainage Device in Glaucoma, sponsored by Al Watany Eye Hospital.

Who is sponsoring NCT05797350?

NCT05797350 is sponsored by Al Watany Eye Hospital.

What drugs are being tested in NCT05797350?

Interventions in NCT05797350: Glaucoma Drainage Device.

Is NCT05797350 still recruiting?

NCT05797350 is currently status unknown. Last updated 4 April 2023.

Last reviewed 2023-04-04 · How we verify

NCT05797350

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Paul Glaucoma Implant Versus Ahmed Glaucoma Valve in Childhood Glaucoma

Status unknown NA Last updated 4 April 2023

What this trial tests

NA trial testing Glaucoma Drainage Device in Glaucoma in 24 participants. Status unknown.

Timeline

1 September 2022

Primary endpoint
1 June 2024

1 December 2024

Quick facts

Lead sponsor	Al Watany Eye Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	24
Start date	1 September 2022
Primary completion	1 June 2024
Estimated completion	1 December 2024
Sites	1 location across Egypt

Drugs / interventions tested

Glaucoma Drainage Device

Conditions studied

Glaucoma — all drugs for Glaucoma →

Sponsor

Al Watany Eye Hospital

Who can join

Adults 0 to 18, any sex, with Glaucoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomized controlled trial comparing the efficacy and safety of Paul glaucoma implant and Ahmed glaucoma valve in refractory childhood glaucoma patients

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Glaucoma

Currently open trials in the same condition.

NCT07455786 — Modified Trabeculectomy After Failure of Combined Phaco With GATT · NA · recruiting
NCT07298356 — Automated Applanation Tonometry - Updated · NA · recruiting
NCT07217678 — Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use · Phase 4 · recruiting
NCT07145073 — Repetitive Transcranial Alternating Current Stimulation (rtACS) for the Treatment of Optic Neuropathies · NA · recruiting
NCT07209410 — Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanopro · Phase 4 · recruiting

Other Al Watany Eye Hospital trials

Trials by the same sponsor.

NCT06062004 — Evaluation of Different Lenticule Diameters in Myopic Astigmatism Correction With SMILE Procedures · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05797350 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Al Watany Eye Hospital
Last refreshed: 4 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05797350.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing